Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02785133 · ClinicalTrials.gov registry record · NA
Safety and Feasibility of Polychromatic Light Emitting Diode for Peripheral Catheter Illumination During Peripheral Intravenous Delivery of Normal Saline
A NA study of Fatigue and Quality of Life, sponsored by UVLrx Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 3,063
- Enrollment target
- 1
- Study location
NCT02785133 is a NA study of Fatigue and Quality of Life that has completed, run by UVLrx Therapeutics. The registered enrollment target is 3,063 participants, above the 190-participant average among 109 other Fatigue trials with a reported enrollment target (1512% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02785133, a NA study of Fatigue and Quality of Life, has completed, sponsored by UVLrx Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,063 participants
- Enrollment target
- 1
- Study location
Study Summary
This study uses a prospective non-randomized, non-controlled design. Five-hundred (500) subjects having previously received a peripheral intravenous therapy will be enrolled into a single treatment group. The purpose of the study is to evaluate the safety, feasibility, and improved energy levels following treatment with a low-light source integrated into an existing peripheral intravascular catheter. The absence of a control group is based on the following reason:This is a pilot investigation to establish a baseline understanding of the safety, feasibility, and cursory utility of polychromatic light emitting diodes integrated into an existing 20-gauge 1.0 inch intravenous catheter to improve self-reported overall subject energy levels.
Conditions Studied
Interventions
- DEVICE UVL1000 Treatment Station
- DRUG Normal Saline Solution
- DEVICE Peripheral Catheterization
Study Locations (1)
Texas
- Lozano Medical Clinic - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,063 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02785133
The ClinicalTrials.gov registry entry for NCT02785133 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,063 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 190-participant average among 109 other Fatigue trials with a reported enrollment target (1512% higher). The listed sponsor is UVLrx Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Fatigue appearing as the primary indexed condition, and to 3 interventions - of which UVL1000 Treatment Station is the first listed.
NCT02785133 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02785133 about?
NCT02785133 is a clinical study titled "Safety and Feasibility of Polychromatic Light Emitting Diode for Peripheral Catheter Illumination During Peripheral Intravenous Delivery of Normal Saline". This study uses a prospective non-randomized, non-controlled design. Five-hundred (500) subjects having previously received a peripheral intravenous therapy will be enrolled into a single treatment group. The purpose of the study is to evaluate the safety, feasibility, and improved energy levels fol...
What is the current status of trial NCT02785133?
This trial is currently completed. It is a NA study. The enrollment target is 3,063 participants. The study started on 2014-12. Estimated completion is 2016-10.
What conditions does trial NCT02785133 study?
This clinical trial studies the following conditions: Fatigue, Quality of Life.
What interventions are being tested in trial NCT02785133?
The interventions under investigation include: UVL1000 Treatment Station (DEVICE), Normal Saline Solution (DRUG), Peripheral Catheterization (DEVICE).
Who is sponsoring clinical trial NCT02785133?
This trial is sponsored by UVLrx Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02785133 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fatigue and Cognitive Demand With Aging
RECRUITING · NA
-
Behavioral and Neural Correlates of Post-Stroke Fatigue
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
RECRUITING · NA
-
Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.